{
    "clinical_study": {
        "@rank": "147987", 
        "arm_group": [
            {
                "arm_group_label": "Pneumostem\u00ae", 
                "arm_group_type": "Experimental", 
                "description": "A single intratracheal administration of Pneumostem\u00ae (1.0 x 10^7 cells/kg)"
            }, 
            {
                "arm_group_label": "normal saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "A single intratracheal administration of normal saline"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a follow-up study to investigate the long-term safety and efficacy of PNEUMOSTEM\u00ae\n      versus placebo, for the treatment of BPD in premature infants. Subjects who participated in\n      and completed the initial stage of the Phase II trial (NCT01297205 ) will be followed-up\n      until 60 months of corrected age."
        }, 
        "brief_title": "Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM\u00ae Phase-II Clinical Trial", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Bronchopulmonary Dysplasia", 
        "condition_browse": {
            "mesh_term": "Bronchopulmonary Dysplasia"
        }, 
        "detailed_description": {
            "textblock": "Subjects who completed the initial stage of the Phase II clinical trial will be followed-up\n      at 7 additional visits: corrected age of 6, 12,18, 24, 36, 48, and 60 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject who completed the safety and efficacy evaluations in Pneumostem Phase II\n             clinical trial\n\n          -  Subject  with a written consent form signed by a legal representative or a parent\n             upon explanation of the clinical trial\n\n        Exclusion Criteria:\n\n          -  Subject whose parent or legal representative does not agree to participate in the\n             study\n\n          -  subject who is considered inappropriate to participate in the study by the\n             investigator"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "7 Months", 
            "minimum_age": "7 Months"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01897987", 
            "org_study_id": "MP-CR-009-FU"
        }, 
        "intervention": [
            {
                "arm_group_label": "Pneumostem\u00ae", 
                "intervention_name": "Pneumostem\u00ae", 
                "intervention_type": "Biological", 
                "other_name": "Human umbilical cord blood-derived mesenchymal stem cells"
            }, 
            {
                "arm_group_label": "normal saline", 
                "intervention_name": "normal saline", 
                "intervention_type": "Biological", 
                "other_name": "normal saline"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Human Umbilical Cord Blood Derived Mesenchymal Stem Cells", 
            "Bronchopulmonary dysplasia", 
            "Premature infants"
        ], 
        "lastchanged_date": "November 18, 2013", 
        "link": {
            "description": "Pneumostem- Phase I", 
            "url": "https://register.clinicaltrials.gov/prs/app/action/SelectProtocol?sid=S0002T1G&selectaction=View&uid=U0000NAG&ts=116&cx=51y1dz"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Samsung Medical Center"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Asan Medical Center"
                }, 
                "investigator": {
                    "last_name": "Ai-Rhan Kim, Md, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Follow-up Safety and Efficacy Evaluation on Subjects Who Completed the Initial Stage of PNEUMOSTEM\u00ae Phase-II Clinical Trial", 
        "overall_contact": {
            "email": "wioh@medi-post.co.kr", 
            "last_name": "Wonil Oh, MD, PhD", 
            "phone": "+82-2-3465-6670"
        }, 
        "overall_official": [
            {
                "affiliation": "Department of Pediatrics, Samsung Medical Center", 
                "last_name": "Wonsoon Park, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Department of Neonatology, Asan Medical Center", 
                "last_name": "Ai-Rhan Kim, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Respiratory outcome: readmission rate and duration of the hospital stay due to respiratory infection", 
            "safety_issue": "No", 
            "time_frame": "6, 12, 18, 24, 36, 48, and 60 months, corrected age"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01897987"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Whether the subject is receiving medical treatments and if so, duration of the treatment (use of oxygen, steroid, or brochodilator)", 
                "safety_issue": "No", 
                "time_frame": "6, 12, 18, 24, 36, 48, and 60 months, corrected age"
            }, 
            {
                "description": "Total number of admissions to Emergency Room and number of admissions to Emergency Room due to resiratory problems", 
                "measure": "Number of admissions to Emergency Room", 
                "safety_issue": "No", 
                "time_frame": "6, 12, 18, 24, 36, 48, and 60 months, corrected age"
            }, 
            {
                "measure": "Survival", 
                "safety_issue": "No", 
                "time_frame": "6, 12, 18, 24, 36, 48, and 60 months, corrected age"
            }, 
            {
                "measure": "Growth measured by Z-score", 
                "safety_issue": "No", 
                "time_frame": "6, 12, 18, 24, 36, 48, and 60 months, corrected age"
            }, 
            {
                "measure": "Neurological developmental status on K-ASQ, Bayley Scale, Gross Motor Function Classification System (GMFCS) for Cerebral Palsy", 
                "safety_issue": "No", 
                "time_frame": "24 months, corrected age"
            }, 
            {
                "measure": "Deafness or Blindness", 
                "safety_issue": "No", 
                "time_frame": "24 months, corrected age"
            }, 
            {
                "measure": "Number of adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "6, 12, 24,36, 48, and 60 months, corrected age"
            }, 
            {
                "measure": "Significant changes in vital signs", 
                "safety_issue": "Yes", 
                "time_frame": "6, 12, 24, 36, 48, and 60 months, corrected age"
            }, 
            {
                "measure": "Significant changes in physical exam", 
                "safety_issue": "Yes", 
                "time_frame": "6, 12, 24, 36, 48, and 60 months, corrected age"
            }
        ], 
        "source": "Medipost Co Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medipost Co Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}